Contact us
Observe Medical ASA
Dronning Eufemias gate 16
0191 Oslo, Norway
order@observemedical.com
© All Rights Reserved
Observe Medical ASA 2022
Observe Medical ASA 2022
About Observe Medical
Observe Medical is a Nordic medtech company that develops, markets and sells innovative medtech products for the global market. The company is committed to improving patient welfare and outcomes, increase clinical data accuracy and promoting positive health economics.
The company seeks to drive growth by leveraging its expertise in sales and commercialization of
its broad portfolio of medical technology products, mainly within urine output measurement. The
strategic vision is to be a Nordic medtech platform for scalable and profitable growth, product
development, regulatory performance and effective manufacturing.
The Group is headquartered in Oslo, Norway, with R&D, regulatory and distribution operations in
Gothenburg, Sweden. In addition, Observe Medical has established a distributor and partner network
globally.
The current portfolio of proprietary products consists of Sippi®, a CE marked digitalized system for
urine output measurement, the UnoMeter™ portfolio consisting of manual urine output measurement
products and solutions for measuring intra-abdominal pressure.
Key team members
Jørgen Mann
CHIEF EXECUTIVE OFFICER
CEO from February 2024. With nearly 20 years of experience in sales and senior management roles from global medtech companies in Europe, he brings highly relevant experience to Observe Medical, as the company strengthens its commercial efforts in the market.
JOHAN M. FAGERLI
CHIEF FINANCIAL OFFICER
CFO from February 2024. 20 years-experience from various roles within financial management, business controlling and accounting across multiple industries such as real estate, road construction and telecom.
Board of directors
TERJE BAKKEN
CHAIRMAN OF THE BOARD
Terje Bakken is a partner in Reiten & Co AS and has been the chairman of the Board of Directors of the Company since its incorporation in 2019. Mr. Bakken has an extensive Private Equity/Active Ownership experience trough leading and implementing various strategic and operational value-based processes across different industries, combined with a significant financial transaction and structured finance experience. Mr. Bakken holds a Master of Science in Financial Economics degree and Bachelor of Business and Administration degree from the Norwegian School of Management. He currently sits on the board of directors of various companies and has previous board experience from both public and private companies in different industries. Mr. Bakken is a Norwegian citizen and resides in Oslo, Norway
LINE TØNNESSEN
BOARD MEMBER
Line Tønnessen is a partner in Reiten & Co, bringing a strong analytical and strategic background to the Board. Ms. Tønnessen has extensive experience across equity and debt capital markets, bank financing, mergers and acquisitions and sustainability initiatives, as well as brings board-level experience from various other industries and listed companies. She holds a Bachelor of Business Administration from BI Norwegian Business School, an MBA in Finance from the Norwegian School of Economics (NHH), and is a Certified European Financial Analyst (CEFA).
MAY-BRITT MOESLUND- HANSEN
BOARD MEMBER
May-Britt Moeslund-Hansen is CEO and Co-founder of Dialysis International ApS and brings more than 30 years of global experience across healthcare and medtech. She has held roles in both small and large companies, with a strong track record in commercial leadership establishing and scaling businesses across new and existing global markets. She has a broad background in strategy and general management, as well as extensive experience working across healthcare providers and commercial partnerships. She has held senior leadership roles at, among others, Unomedical, NxStage Medical, and Fresenius Medical Care across Europe, the Middle East, Asia, and other global markets.
ANOAR SOLBERG DIAB
BOARD MEMBER
Anoar Solberg is an accomplished leader with over 16 years of experience in the medical device industry, specifically within Abbott Diabetes Care. He possesses a solid, cross-functional background, having led key departments including Sales, Marketing, Market Access, Business Excellence, Business Development and Finance. He holds a M.Sc. in Marketing from BI Norwegian Business School, Oslo. Throughout his career, Anoar has specialized in Go-To-Market Strategies including strategic distributor partnering and managing complex commercial relationships across both mature and emerging markets. Beyond his corporate tenure, Anoar has contributed to the academic landscape for 14 years as a lecturer at two prominent business schools in Oslo, where he mainly taught Strategy, Innovation, and Marketing. His current focus is as an independent consultant providing training and commercial guidance.